Adenosine-2'-5'-Diphosphate
Star0
Identification
- Generic Name
- Adenosine-2'-5'-Diphosphate
- DrugBank Accession Number
- DB02098
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 427.2011
Monoisotopic: 427.029414749 - Chemical Formula
- C10H15N5O10P2
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UEosinophil cationic protein Not Available Humans URibonuclease pancreatic Not Available Humans UNon-secretory ribonuclease Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as purine ribonucleoside 2',5'-bisphosphates. These are purine ribobucleotides with one phosphate group attached to 2' and 5' hydroxyl groups of the ribose moiety.
- Kingdom
- Organic compounds
- Super Class
- Nucleosides, nucleotides, and analogues
- Class
- Purine nucleotides
- Sub Class
- Purine ribonucleotides
- Direct Parent
- Purine ribonucleoside 2',5'-bisphosphates
- Alternative Parents
- Purine ribonucleoside monophosphates / Pentose phosphates / Glycosylamines / 6-aminopurines / Monosaccharide phosphates / Aminopyrimidines and derivatives / Monoalkyl phosphates / Imidolactams / N-substituted imidazoles / Tetrahydrofurans show 8 more
- Substituents
- 6-aminopurine / Alcohol / Alkyl phosphate / Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Azole / Glycosyl compound / Heteroaromatic compound show 29 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- AEOBEOJCBAYXBA-KQYNXXCUSA-N
- InChI
- InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(25-27(20,21)22)6(16)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1
- IUPAC Name
- {[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan-2-yl]methoxy}phosphonic acid
- SMILES
- [H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
References
- General References
- Not Available
- External Links
- KEGG Compound
- C03850
- PubChem Compound
- 440141
- PubChem Substance
- 46504615
- ChemSpider
- 389137
- BindingDB
- 11941
- ChEMBL
- CHEMBL1161861
- ZINC
- ZINC000004096223
- PDBe Ligand
- A2P
- PDB Entries
- 1fnc / 1fnd / 1h1h / 1hi3 / 1o0o / 2gz2 / 2iyp / 2ok7 / 2vni / 3jqp … show 12 more
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 3.29 mg/mL ALOGPS logP -1.6 ALOGPS logP -5.4 Chemaxon logS -2.1 ALOGPS pKa (Strongest Acidic) 0.35 Chemaxon pKa (Strongest Basic) 4.84 Chemaxon Physiological Charge -4 Chemaxon Hydrogen Acceptor Count 12 Chemaxon Hydrogen Donor Count 6 Chemaxon Polar Surface Area 232.6 Å2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 84.94 m3·mol-1 Chemaxon Polarizability 33.92 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.6013 Blood Brain Barrier + 0.9468 Caco-2 permeable - 0.7357 P-glycoprotein substrate Non-substrate 0.7509 P-glycoprotein inhibitor I Non-inhibitor 0.8997 P-glycoprotein inhibitor II Non-inhibitor 0.9427 Renal organic cation transporter Non-inhibitor 0.9469 CYP450 2C9 substrate Non-substrate 0.8683 CYP450 2D6 substrate Non-substrate 0.8452 CYP450 3A4 substrate Non-substrate 0.5892 CYP450 1A2 substrate Non-inhibitor 0.9132 CYP450 2C9 inhibitor Non-inhibitor 0.9186 CYP450 2D6 inhibitor Non-inhibitor 0.8967 CYP450 2C19 inhibitor Non-inhibitor 0.9197 CYP450 3A4 inhibitor Non-inhibitor 0.9286 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9677 Ames test Non AMES toxic 0.8208 Carcinogenicity Non-carcinogens 0.8961 Biodegradation Not ready biodegradable 0.9781 Rat acute toxicity 2.2875 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9716 hERG inhibition (predictor II) Non-inhibitor 0.8892
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsEosinophil cationic protein
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Ribonuclease activity
- Specific Function
- Cytotoxin and helminthotoxin with low-efficiency ribonuclease activity. Possesses a wide variety of biological activities. Exhibits antibacterial activity, including cytoplasmic membrane depolariza...
- Gene Name
- RNASE3
- Uniprot ID
- P12724
- Uniprot Name
- Eosinophil cationic protein
- Molecular Weight
- 18385.145 Da
References
2. DetailsRibonuclease pancreatic
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Ribonuclease a activity
- Specific Function
- Endonuclease that catalyzes the cleavage of RNA on the 3' side of pyrimidine nucleotides. Acts on single-stranded and double-stranded RNA.
- Gene Name
- RNASE1
- Uniprot ID
- P07998
- Uniprot Name
- Ribonuclease pancreatic
- Molecular Weight
- 17644.125 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
3. DetailsNon-secretory ribonuclease
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Ribonuclease activity
- Specific Function
- This is a non-secretory ribonuclease. It is a pyrimidine specific nuclease with a slight preference for U. Cytotoxin and helminthotoxin. Selectively chemotactic for dendritic cells. Possesses a wid...
- Gene Name
- RNASE2
- Uniprot ID
- P10153
- Uniprot Name
- Non-secretory ribonuclease
- Molecular Weight
- 18354.09 Da
References
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52